Skip to main content
. 2011 Nov 23;302(4):F466–F476. doi: 10.1152/ajprenal.00495.2011

Fig. 7.

Fig. 7.

Bar graphs show perfusion pressure responses to exogenous norepinephrine before (basal) and during treatment with CCPA (3 nmol/l) without (A) or with pretreatment with either U73122 (1 μmol/l; B), GF109203X (3 μmol/l; C), PP1 (1 μmol/l; D), wortmannin (0.2 μmol/l; E), or OSU-03012 (0.5 μmol/l; F). Basal perfusion pressures (before treatments) were 54 ± 4, 47 ± 3, 51 ± 2, 49 ± 2, 43 ± 1, and 40 ± 2 mmHg in the no inhibitor group, U73122 group, GF109203X group, PP1 group, wortmannin group, and OSU-03012 group, respectively, and were not affected by the treatments. aP < 0.05 compared with basal response in same group. bP < 0.05 compared with responses in presence of CCPA in no inhibitor group. Values represent means ± SE for the indicated number of experiments (n).